Framework Agreement For Producer Cell Line For GMP Viral Vector Packaging
NHSBT's Clinical Biotechnology Centre has a requirement for specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins.
The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials.
In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required
Make the case to bid
Reveal who to approach at NHS Blood & Transplant, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- ddb492e1-255a-4c98-85fd-647c041c5232
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- tender_241645/858616
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
Assembling the market network…
NHS Blood & Transplant’s tender network
Assembling the network…